
An antibody combination treatment delivered through an injection has shown statistically significant reduction in severe Covid-19 or death compared to placebo in non-hospitalised patients with mild-to-moderate symptomatic Covid-19, AstraZeneca reported on Monday. MORE..
from AdaDerana RSS https://ift.tt/3v2YUHT
via
IFTTT
إرسال تعليق